Exciting news for anyone passionate about healthcare innovation—iDR25, the International Drug Repurposing Conference, is coming up on 7-8th May 2025 in the beautiful city of Amsterdam in The Netherlands!
“Finding new medicines for each disease where there is no existing treatment may take centuries. We can help fill this gap faster, cheaper and more safely by repurposing approved drugs and repositioning investigational drugs.”
-Donald Lo, Director for Medicines Development at EATRIS and Scientific Lead of REMEDi4ALL
Why join us at iDR25?
This event offers a unique opportunity to learn from pioneers in drug repurposing, with insights from successful real-world projects. Beyond the science, iDR25 provides a chance to influence policy, discover the regulatory pathways that are advancing access to medicines, and explore how drug repurposing can have a lasting impact on public health. Besides that, we will provide you with plenty opportunities to network. Dedicated sessions and collaboration opportunities will connect you with experts and stakeholders across the entire drug repurposing pipeline. Whether you’re aiming to build on current collaborations or create new ones, iDR25 is the ideal event to make it happen. Additionally, you will explore sustainable business models and learn how different sectors can collaborate to drive mutual benefits, ensuring that innovative treatments make it to patients faster.
Who is iDR25 for?
We actively welcome diverse stakeholders from the entire drug repurposing industry: Patient organisations, researchers, academia, funders, representatives from governments and regulatory, policy makers and many more.
Our first Drug Repurposing Conference, iDR24, was a huge success.
“The enthusiasm for the potential of drug repurposing to transform lives was infectious! It feels like the field is at a turning point. Well done in a great event #iDR24”.
– iDR24 Attendee
iDR24 drew a diverse group of 230 attendees from 19 countries, representing key players across academia, government, non-profits, industry, and patient communities. With over 50 speakers and 51 talks focused on cancer, rare diseases, and innovative methodologies, the event was packed with insights from research, regulatory bodies, health authorities, and the pharmaceutical sector. Attendees also had the chance to explore 28 poster presentations, showcasing both competitive and project-related research. Moreover, the conference captured the attention of major media outlets like “El país” (Spain´s most read newspaper) and “Le Figaro “(largest daily newspaper in France), as well as active engagement on social media.
We look forward to continuing this exciting journey in drug repurposing with you!
Click here for more information: Join iDR25, the international drug repurposing conference (remedi4all.org) and
Register on Eventbrite. iDR25 is organised by REMEDi4ALL in collaboration with Beacon. To hear latest updates on iDR25, follow REMEDi4ALL on social media or sign up to our newsletter.
